Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2021-12-02 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory announcement regarding trading mechanics, not a comprehensive financial report (like 10-K or IR) or a management/board change. Given the nature of the announcement (a brief update disseminated via the RNS system) and the lack of fit into more specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory announcement category.
2021-12-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 0384U'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement that does not fit into the specific financial report categories (like 10-K, ER, IR). Therefore, the most appropriate classification is the general regulatory filing fallback category, RNS.
2021-11-30 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 0371U' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security's auction call period. This is a general regulatory announcement that does not fit the specific categories like ER, 10-K, or DIV. According to Rule 2, since it is a short announcement from the regulatory news service (RNS), it should be classified as a Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing a report. Since it is a direct, short regulatory update about trading mechanics, RNS is the most appropriate fallback category.
2021-11-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 9366T' and contains information about a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly mentions RNS as the news service approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. This type of short, immediate regulatory update regarding trading mechanics or market status, distributed via the RNS system, fits best under the general 'Regulatory Filings' category, as it is not a standard financial report (10-K, IR, ER) or a specific corporate action like a dividend or management change. Given the source and nature (a brief, time-sensitive market notice), RNS is the most appropriate classification.
2021-11-29 English
Price Monitoring Extension
Share Issue/Capital Change Classification · 1% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange.' It announces a 'Price Monitoring Extension' related to trading activity, which is a specific, non-financial regulatory announcement concerning market operations. Since it is a general regulatory announcement that doesn't fit into the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (1914 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this type of market notice.
2021-11-29 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 9185T'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of immediate, short-form regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing, which corresponds to the RNS code. It is not an announcement of a report (RPA), but a direct regulatory notice.
2021-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.